NEUROBO PHARMACEUTICALS
NeuroBo Pharmaceuticals is addressing unmet needs in patients with diabetic neuropathy and Alzheimerโs disease. Their Phase III-ready drug, NB-01, is based on natural sources and has shown successful Phase II results with excellent efficacy and safety in diabetic neuropathic pain (DNP) and they have strong preclinical data in both neuropathic pain and diabetes models showing a mode of action of NB-01 on nerve growth factor (NGF) release for nerve stabilization and regeneration. 40 to 50 perc... ent of patients with diabetic peripheral neuropathy have some form of neuropathic pain and while existing drugs alleviate pain symptoms, they do not address the underlying disease. These current therapies also have a range of adverse effects, and only about 50 percent of patients respond positively. Additionally, the current therapies on the market were all initially approved for other disease states such as depression and fibromyalgia. NB-02, their lead Alzheimerโs drug, is in IND-enabling stage and has been extensively characterized in rodent models for mechanisms impacting Alzheimerโs disease (inhibition of AChE, pTau, amyloid-ฮฒ, and stimulation of NGF for nerve growth. An aging population has resulted in an increase in the prevalence of Alzheimerโs disease, and the disease is a significant healthcare burden. Today, there are four approved drugs that manage the symptoms of Alzheimerโs disease, yet none of these four address disease modification.
NEUROBO PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2014-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.neurobopharma.com
Total Employee:
1+
Status:
Active
Contact:
+1 857 702 9600
Email Addresses:
[email protected]
Total Funding:
69.44 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Google Maps GoDaddy DNS Squarespace Hosted Barracuda Networks
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Concert Pharmaceuticals
Concert Pharmaceuticals is a biotechnology company utilizing deuterium to develop novel medical candidates.
Electra Therapeutics
Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.
Exuma Biotech
EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-12-31 | ANA Therapeutics | ANA Therapeutics acquired by NeuroBo Pharmaceuticals | 17.03 M USD |
| 2019-12-31 | Gemphire Therapeutics | Gemphire Therapeutics acquired by NeuroBo Pharmaceuticals | N/A |
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - NeuroBo Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-04 | NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer |
Official Site Inspections
http://www.neurobopharma.com Semrush global rank: 8.65 M Semrush visits lastest month: 274
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
